FDA Approved Medical Products for:

Chronic inflammatory demyelinating polyneuropathy

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Immune Globulin (Human)
Trade Name
(Manufacturer Name)
Gamunex®
(Talecris)
Indication
The FDA has approved this product to be used in this manner.
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse
More Information about this product Drug Information Portal
Medline Plus Health Information